Clinical Effect and Analysis of Prognostic Factors of the Elder Patients with Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization
刘嵘,王建华,颜志平,钱晟,程洁敏,龚高全,刘清欣,陈颐,罗剑钧
DOI: https://doi.org/10.3969/j.issn.1009-4393.2009.05.018
2009-01-01
Abstract:Objective To evaluate the clinical effect and analyze the major prognostic factors of transcatheter arterial chemoembolization(TACE)to the elder patients(elder than 65 years)with unresectable hepatocellular carcinoma(HCC).Materials and Methods 96 patients with HCCs elder than 65 years treated with TACE were studied retrospectively.The clinical data,therapeutic protocols and follow-up after TACE were analyzed.TACE procotol was FUDR 500～750mg,CDDP 40～60mg,Lipiodl 5～20ml mixed with MMC20mg/EADM 30～50mg,and only Lipiodl mixed with MMC20mg/EADM 30～50mg for embolization was used in 46 patients.The rate of complication,the cause of death were recorded.Cumulative survival rates were calculated with the Kaplan-Meier method.Univariable analysis and multivariate Cox proportional hazard regression model were used to analyze the factors affecting the prognosis.Results(1)The overall cumulative survival rates for 6,12,24,36,and 60 months were 91.7%,71.9%,38.2%,30.5% and 23.8% respectively and the median survival time was 19 months.(2)Univariate analysis showed that Child grade of liver function,clinical stage,tumor number,tumor size,portal venous tumor thrombus,AVF,extrahepatic spread,tumor regression rate and concurrent disease were significant prognostic factors.(3)Multivariate analysis showed that tumor number,tumor size,portal venous tumor thrombus,AVF,concurrent disease were significant prognostic factors.Conclusion Factors of tumor and Child grade of liver function can affect the long-term survival,on the other hand,concurrent disease is also the key factor for the elder HCC patients.To prevent and manage the concurrent disease effectively can prolong the survival time and improve the long-term prognosis.